Fermented pomegranate (Punica granatum) peel extract as a novel anticancer agent targeting angiogenesis and metastasis

International Journal of Toxicological and Pharmacological Research

Volumn 6, Issue 4, 2014, Pages 60-66

  Mahmoud, Abeer E ^a   Ali, Mamdouh M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Angiogenesis; Anticancer; Fermentation; Metastasis; Pomegranate

Indexed keywords

DOXORUBICIN; ELASTASE; HISTONE DEACETYLASE; POMEGRANATE EXTRACT; UROKINASE; VASCULOTROPIN;

A549 CELL LINE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FERMENTED PRODUCT; HCT116 CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; METASTASIS INHIBITION; PROSTATE CANCER CELL LINE;

EID: 84916594814     PISSN: None     EISSN: 09755160     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ho JW, Leung YK and Chan CP (2002) Herbal medicine in the treatment of cancer. Curr Med Chem Anticancer Agents 2:209-214.
2. Velmurugan B, Singh RP, Kaul N, Agarwal R and Agarwal C (2010) Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APC min/+ mice. Neoplasia 12:95-102.
3. Afaq F, Saleem, M, Krueger CG, Reed JD and Mukhtar H (2005) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappa B pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 113:423-433.
4. Prashanth D, Asha MK and Amit A (2001) Antibacterial activity of Punica granatum. Fitoterapia 72:171-173.
5. Das AK, Mandal SC, Banerjee SK, Sinha S, Das J, Saha BP and Pal M (1999) Studies on antidiarrhoeal activity of Punica granatum seed extract in rats. J Ethnopharmacol 68:205-208.
6. Dutta BK, Rahman I and Das TK (1998) Antifungal activity of Indian plant extracts. Mycoses 41:535-536.
7. Gharzouli K, Khennouf S, Amira S and Gharzouli A (1999) Effects of aqueous extracts from Quercus ilex L. root bark, Punica granatum L. fruit peel and Artemisia herba-alba Asso leaves on ethanol-induced gastric damage in rats. Phytother Res 13:42-45.
8. Sivarajan, V.V. and Balachandran, I. Ayurvedic drugs and their plant sources, London: Oxford and IBH Publishing Co Pvt. Ltd., 1994.
9. Jayaprakasha GK, Sigh RP and Sakariah KK (2001) Antioxidant activity of grape seed (Vitis vinifera) extracts on peroxidation models in vitro. Food Chem 73:285-290
10. Mahmoud AE and Ali MM (2012) Attenuation the side effects of adriamycin- induced cardiotoxicity and nephrotoxicity in rats by fermented Punica granatum (pomegranate) peel extract. International Journal of Research in Pharmaceutical Science 3: 29-37.
11. Lee YL, Yang JH. and Mau JL (2008) Antioxidant properties of water extracts from Monascus fermented soybeans. Food Chem 106:1128-1137.
12. Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10:39-49.
13. Syrovets T and Simmet T (2004) Novel aspects and new roles for the serine protease plasmin. Cell Mol Life Sci 61:873-885.
14. Mignatti P and Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195.
15. Bdeir K, Kuo A and Sachais BS (2003) The kringle stabilizes urokinase binding to the urokinase receptor. Blood 102:3600-3608.
16. Blasi F and Carmeliet P (2002) uPAR: A versatile signalling orchestrator. Nat Rev Mol Cell Biol 3:932-943.
17. Andreasen PA, Kjoller L, Christensen L and Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 72:1-22.
18. Meyer T and Hart IR (1998) Mechanisms of tumour metastasis. Eur J Cancer 34:214-221.
19. Sidenius N and Blasi F (2003) The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22:205-222.
20. Duffy MJ and Duggan C (2004) The urokinase plasminogen activator system: A rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem 37:541-548.
21. Hu E, Chen Z, Fredrickson T, Zhu Y, Kirkpatrick R, Zhang GF, Johanson K, Sung CM, Liu R and Winkler J (2000) Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem 275:15254-15264.
22. Komatsu Y and Hayashi H (1998) Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells. J Antibiot 51:89-91.
23. Komatsu Y, Tomizaki K, Tsukamoto M, Kato T, Nishino N, Sato S, Yamori T, Tsuruo T, Furumai R, Yoshida M, Horinouchi S and Hayashi H (2001) Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Cancer Research 61:4459-4466.
24. Emile EV and Patricia AD: Tumor angiogenesis and microcirculation. Marcel Dekker Inc., New York, 2001, 1–8.
25. Borgström P, Hillan KJ, Sriramarao P and Ferrara N (1996) Complete inhibition of angiogenesis and growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56:4032-4039.
26. Benjamin LE, Golijanin D, Itin A, Pode D and Keshet E (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159-165.
27. Nicolson GL (1989) Metastasis tumor cell interactions with endothelium, basement membrane and tissue. Curr Opinion Cell Biol 1:1009-1019.
28. Zelvyte I, Stevens T, Westin U and Janciauskiene S (2004) Alpha-1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil- conditioned medium on lung cancer HCC cells In vitro. Cancer Cell International 4:4-7.
29. Taniguchi K, Yang P, Jett J, Bass E, Meyer R, Wang Y, Deschamps C and Liu W (2002) Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clinical Cancer Research 8:1115-1120.
30. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute 82:1107-1112.
31. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193:265-275.
32. Zay K, Loo S, Xie C, Devine DV, Wright J and Churg A (1999) Role of neutrophils and alpha-1-antitrypsin in coal- and silica-induced connective tissue breakdown. Am J Physiol 276: L269-L279.
33. Bradury RH. Cancer. In: Topics in medicinal chemistry. Vol. 1, Springer-Verlag, Berlin, 2007, 345-80.
34. Law PC, Auyeung KK, Chan LY and Ko JK (2012) Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. BMC Complementary and Alternative Medicine12:160-171.
35. Troiani T, Lockerbie O, Morrow M, Ciardiello F, Eckhardt SG (2006) Sequence dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases. Mol Cancer Ther 5:1883-1894.
36. Roskoski R Jr (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62:179-213.
37. Belotti D, Paganoni P, Manenti L, Garfalo A, Marchini S, Taraboletti G and Giavazzi R (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63:5224-5229.
38. Bhoopathi P, Chetty C, Kunigal S, Vanamala SK, Rao JS and Lakka SS (2008) Blockade /integrin, ERK and NF-κB. J Biol Chem 283:1545-1552.
39. Ginzberg HH, Cherapanov V, Dong Q, Cantin A, McCulloch AG, Shannon PT and Downey GP (2001) Neutrophil-mediated epithelial injury during transmigration: Role of elastase. Am J Physiol Gastrointest Liver Physiol 281:G705-717.